Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/13/22
End: 11/02/22
Due: 11/02/23
Phase: N/A
Priority: Normal
Start: 06/09/22
End: 10/30/24
Due: 10/30/25
Phase: N/A
Priority: Normal
Start: 10/11/18
End: 10/25/19
Due: 10/25/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study of AG-80308 in Dry Eye Patients | NCT05372107 | Allgenesis Biotherapeutics Inc. | user2@example.com | None | 2022-06-13 | 2022-11-02 | 2023-11-02 | - | - | 2025-07-14 |
| AG-73305 Single Ascending Dose Cohort Study in DME | NCT05301751 | Allgenesis Biotherapeutics Inc. | user2@example.com | None | 2022-06-09 | 2024-10-30 | 2025-10-30 | - | - | 2025-07-14 |
| A Study of the Response to AG-86893 in Patients With Pterygium Hyperemia | NCT03533244 | Allgenesis Biotherapeutics Inc. | user2@example.com | None | 2018-10-11 | 2019-10-25 | 2020-10-25 | - | - | 2025-07-14 |